GLOBUS MEDICAL INC acquired Nemaris, Inc. for approximately $15.2 million (asset purchase), a transaction completed in September 2018, structured as all cash. The deal was a Asset purchase.
Nemaris, Inc. operates in Enabling technology — surgical planning software, is based in USA. Nemaris, Inc. is a privately held company that markets and develops Surgimap, a surgical planning software platform; substantially all of the acquired value was in developed technology.
Adds the Surgimap surgical planning software platform and developed technology to Globus's enabling-technology portfolio.
Adds the Surgimap surgical-planning software and its developed technology to Globus's enabling-technology suite. Integrated into Globus Medical's enabling-technology / software portfolio
On September 5, 2018, we acquired Nemaris, Inc. ("Nemaris"), a privately held company that markets and develops Surgimap, a surgical planning software platform. ... the Nemaris Acquisition was accounted for as an asset purchase. We allocated the consideration paid of $15.2 million on a pro rata basis to the assets acquired.Globus Medical, Q2 2019 Form 10-Q, Business Combinations note
Advisory firms were not disclosed for this transaction.